NPCE
NeuroPace Inc
Key Financials
Revenue
$100.0M
↑ 25.1%
Operating Income
$-16338000
↑ 24.6%
Net Income
$-21465000
↑ 20.9%
Gross Profit
$77.2M
↑ 30.7%
EPS (Diluted)
$-0.66
↑ 29.0%
Shareholders' Equity
$19.0M
↑ 137.5%
Total Assets
$105.6M
↑ 11.5%
Cash & Equivalents
$21.7M
↑ 61.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 10-Q | 5/12/2026 | View on SEC |
| 8-K | 5/12/2026 | View on SEC |
| ARS | 4/21/2026 | View on SEC |
| DEFA14A | 4/21/2026 | View on SEC |
| DEF 14A | 4/21/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NPCE |
| Company Name | NeuroPace Inc |
| CIK | 1528287 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 6502372700 |